Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients

Table 4 Impact of duration post transplant on the parameters at the end of therapy

Parameters	Duration post transplant		P value
	> 49 mo(n = 10)	< 49 mo(n = 9)
AST (U/L)	27.6	36.44	0.63
ALT (U/L)	33.4	28.33	0.59
HCV-RNA (log10 IU/mL)	2.38	2.94	0.72
WBC (109/L)	4.38	5.73	0.59
Hemoglobin (G/L)	107	93.44	0.28
Creatinine (Umol/L)	161.80	112.78	0.15
GFR (mL/min)	61.90	75.22	0.37

AST: Aspartate aminotransferase; ALT: Abnormal alanine aminotransferase; HCV: Hepatitis C virus; WBC: White cell count; GFR: Glomerular filtration rate.